Hargabka ka dillaacay Yurub iyo Maraykanka, mareenka neef-mareenka ayaa ah midka ugu jecel

Maqnaanshaha hargabka ee labada sano ah ayaa bilaabay inuu mar kale ka dillaaco Maraykanka iyo dalal kale, taas oo ka farxisay shirkado badan oo Yurub iyo Ameerika ah IVD, maadaama suuqa Newcrest multiplex uu u keeni doono korriin dakhli oo cusub, halka xarumaha Flu B ay u baahan yihiin multiplex oggolaanshaha FDA ayaa bilaaban kara.
Kahor faafidda cudurka Crown-ka cusub, fayraska hargabka (Flu A iyo Flu B) waxay cudurro u geysteen tobanaan milyan oo Maraykan ah, iyo tobanaan kun oo dhimasho ah, jiilaal kasta. Xilliga jiilaalka ee 2018-2019, hargabku wuxuu sababay 13 milyan oo booqasho, 380,000 isbitaal iyo 28,000 oo dhimasho ah. Labadii sano ee la soo dhaafay, si kastaba ha ahaatee, tirada dadka uu ku dhacay hargabka iyo RSV ayaa hoos u dhacday iyadoo cudurka faafa ee taajka cusub uu sababay xirashada maaskaro baahsan, fogeynta bulshada iyo xiritaanka dugsiyada iyo xarumaha xanaanada.
Sida dunidu u jiifto oo taxaddarkii qaranka laga tagay, xilli hargabku waa soo noqday, iyo xilli-ciyaareedka 2022 ayaa soo socda wax yar ka hor waxaana saadaaliyay khubarada caafimaadka bulshadu inay ka sii xumaan doonaan ka hor faafitaanka New Crown. Shaxda hoose waxay muujineysaa tirakoobkii ugu dambeeyay ee CDC ee tirada dadka cusbitaalka loo dhigay hargabka dartii, waxaana cad in xilliga hargabka 2022 uu aad uga horeeyo sidii hore.

v Tirakoobka CDC ee wadarta boqolkiiba sannadlaha ee hargabka la xaqiijiyay (Toddobaka 40 ee 2021 waa Oktoobar 3)

Faafitaanka hargabka lama la socon hagaajinta faafitaanka taajka cusub ee Maraykanka, maadaama saamiga noocyada cusub ee BQ.1.1, BQ.1 iyo BF.7 ay sii wateen inay sii ballaariyaan, iyadoo saddexda nooc ee ugu sarreeya ee kala duwanaanshuhu ay ku badan yihiin Maraykanka. Dawladaha laga bilaabo 30 Oktoobar ilaa 5 Noofambar waa: BA.5 (39.2%), BQ.1.1 (18.8%) iyo BQ.1 (16.5%). BA.5, BA.1.1, BQ.1 BF.4.6, BF.7 iyo noocyo kale duwan oo kala duwan ayaa isku mar baahay.

Isbeddelladan cusub waxay kordhiyeen badbaadada difaaca ee neo-coronavirus, taasoo keentay in tirada bukaannada cusub ee cudurka 'neo-coronavirus' ee Mareykanka ay kordho dhowaan, si ka duwan waddamada kale. Sida laga soo xigtay CDC, kororka is biirsaday ee tirada hargabka iyo caabuqyada Coronavirus ee cusub ee Mareykanka ayaa horseeday koror weyn oo booqashooyinka isbitaallada ee caabuqyada neefsashada.

Gaar ahaan carruurta uu cudurku si xun u saameeyay sababtoo ah waxay aad u daciifeen hab-dhiska difaaca. Tani waxay inta badan sabab u tahay xaqiiqda ah in carruur badan aysan la kulmin fayraska hargabka/RSV ka hor masiibada cusub ama difaacooda oo daciifay.

CDC waxay xustay in heerarka tallaalka hargabka ee dhammaan kooxaha da'da ay wax yar hoos u dhaceen sannadkii hore marka la barbardhigo sannadkii hore, iyadoo hoos u dhaca ugu weyn ee heerarka tallaalka ee carruurta halista ku jira ee da'doodu tahay 6 bilood ilaa 4 sano, laga bilaabo 75 boqolkiiba ka hor faafitaanka cusub ilaa 67 boqolkiiba. Xogta CDC waxay sidoo kale muujineysaa in saamiga infekshannada hargabka ee carruurta ay si gaar ah u saameynayeen sanadkan, iyagoo kor u dhaafay 10% 3dii toddobaad ee la soo dhaafay.

Tani waxay faa'iido u noqon doontaa shirkadaha IVD ee leh alaabada tijaabinta badan ee Newcrest. Mustaqbalka, suuqa tijaabada Newcrest waxa uu noqon doonaa suuq ay xukumaan Newcrest + Flu A + Flu B badeecooyin badan oo tijaabo ah, marka lagu daro RSV iyo Strep A, kaas oo sidoo kale ay jirto baahi muddo dheer ah.

Shirkaddayadu waxay hore u soo saartay FluA/B iyoSARS-CoV-2badeecooyin badan oo tijaabo ah oo helay shahaadada CEIVD.